Guideline
Chinese guidelines for theTreatment of Parkinson′s disease (fourth edition)
Chinese Society of Parkinson′s Disease and Movement Disorders, Parkinson′s Disease and Movement Disorder Section of Neurologist Branch of Chinese Medical Doctor Association
Published 2020-12-08
Cite as Chin J Neurol, 2020, 53(12): 973-986. DOI: 10.3760/cma.j.cn113694-20200331-00233
Abstract
Parkinson′s disease is a common neurodegenerative disease in middle-aged and elderly people. In recent years, Chinese scholars have made significant progress in the understanding of the pathogenesis of Parkinson′s disease, the discovery of biomarkers for early diagnosis, as well as the renewal of therapeutic strategy. In 2006, 2009 and 2014, Chinese Society of Parkinson′s Disease and Movement Disorders developed the first, second and third edition of the Chinese Parkinson′s disease treatment guidelines. In the past six years, there have been some new progresses in therapeutic strategies. In order to better adapt to the development and guide clinical practice, this article have updated the recently developed therapeutic strategy based on the third edition of treatment guideline.
Key words:
Parkinson disease; Therapeutics; Guideline
Contributor Information
Chinese Society of Parkinson′s Disease and Movement Disorders
Parkinson′s Disease and Movement Disorder Section of Neurologist Branch of Chinese Medical Doctor Association